Genovefa Papanicolaou

9PUBLICATIONS
42CO-AUTHORS
Major global burdens of diseaseDisease surveillanceInnate immunityHaematologyPreventative health care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 17, 2026
Efficacy and Safety of Pritelivir vs Foscarnet for the Treatment of Acyclovir-Refractory Herpes Simplex Virus Infection in Immunocompromised Adults: A Randomized, Open-Label Phase 2 Trial.

|Jul 22, 2026
Refractory Mucocutaneous Infections by Herpes Simplex Virus (HSV) in Hematopoietic Cell Transplant Recipients: A Real-world, Multicenter Study.

|Dec 01, 2025
An Analysis of Cytomegalovirus-Specific Cell-Mediated Immunity in a Phase 3, Randomized, Placebo-Controlled Trial of Letermovir Prophylaxis in Cytomegalovirus-Seropositive Recipients of an Allogeneic Hematopoietic Cell Transplant.

Genovefa A Papanicolaou, Sanjeet S Dadwal, Ella J Ariza-Heredia

|Jan 29, 2025
Refractory and Resistant Herpes Simplex Virus Mucocutaneous Infections in Immunocompromised Patients: Literature Review and Proposed Definitions for Use in Clinical Trials.

Roy F Chemaly, Tali Shafat, Anna Wald

|Oct 31, 2023
Post-transplantation cyclophosphamide is associated with increased bacterial infections.

Celalettin Ustun, Min Chen, Soyoung Kim

|Oct 21, 2023
CMV prevention strategies in allogeneic hematopoietic cell transplantation; the role of prophylaxis and pre-emptive monitoring in the era of letermovir.

Michelle K Yong, Monica A Slavin, Roy F Chemaly

Pageof 2

Frequent Collaborators

3 joint publications

Roy F Chemaly

2 joint publications

Camille N Kotton

2 joint publications

Per Ljungman

2 joint publications

Veronica Miller